| Detection of circulating tumor cells and their implications as a novel biomarker for diagnosis, prognostication, and therapeutic monitoring in hepatocellular carcinoma JC Ahn, PC Teng, PJ Chen, E Posadas, HR Tseng, SC Lu, JD Yang Hepatology, 2021 | 260 | 2021 |
| Purification of HCC-specific extracellular vesicles on nanosubstrates for early HCC detection by digital scoring N Sun, YT Lee, RY Zhang, R Kao, PC Teng, Y Yang, P Yang, JJ Wang, ... Nature communications 11 (1), 4489, 2020 | 157 | 2020 |
| Hepatocellular Carcinoma–Circulating Tumor Cells Expressing PD‐L1 Are Prognostic and Potentially Associated With Response to Checkpoint Inhibitors P Winograd, S Hou, CM Court, YT Lee, PJ Chen, Y Zhu, S Sadeghi, ... Hepatology Communications 4 (10), 1527-1540, 2020 | 75 | 2020 |
| Cost-effective methylome sequencing of cell-free DNA for accurately detecting and locating cancer ML Stackpole, W Zeng, S Li, CC Liu, Y Zhou, S He, A Yeh, Z Wang, F Sun, ... Nat Communication 13 (5566), 2022 | 45 | 2022 |
| Covalent chemistry on nanostructured substrates enables noninvasive quantification of gene rearrangements in circulating tumor cells J Dong, YJ Jan, J Cheng, RY Zhang, M Meng, M Smalley, PJ Chen, ... Science advances 5 (7), eaav9186, 2019 | 41 | 2019 |
| A circulating tumor cell-RNA assay for assessment of androgen receptor signaling inhibitor sensitivity in metastatic castration-resistant prostate cancer YJ Jan, J Yoon, JF Chen, PC Teng, N Yao, S Cheng, A Lozano, GCY Chu, ... Theranostics 9 (10), 2812, 2019 | 22 | 2019 |
| Noninvasive prenatal diagnostics: recent developments using circulating fetal nucleated cells PJ Chen, PC Teng, Y Zhu, YJ Jan, M Smalley, Y Afshar, LC Chen, ... Current obstetrics and gynecology reports 8, 1-8, 2019 | 17 | 2019 |
| Somatic copy number profiling from hepatocellular carcinoma circulating tumor cells CM Court, S Hou, L Liu, P Winograd, BJ DiPardo, SX Liu, PJ Chen, Y Zhu, ... npj Precision Oncology 4 (1), 1-9, 2020 | 12 | 2020 |
| Circulating Tumor Cell–Based Messenger RNA Scoring System for Prognostication of Hepatocellular Carcinoma: Translating Tissue‐Based Messenger RNA Profiling Into a Noninvasive … YT Lee, N Sun, M Kim, JJ Wang, BV Tran, RY Zhang, D Qi, C Zhang, ... Liver Transplantation 28 (2), 200-214, 2022 | 10 | 2022 |
| Multi-feature ensemble learning on cell-free dna for accurately detecting and locating cancer ML Stackpole University of California, Los Angeles, 2020 | 6 | 2020 |
| Targeted Molecular Profiling of Circulating Cell-Free DNA in Patients With Advanced Hepatocellular Carcinoma D Cowzer, JB White, JF Chou, PJ Chen, TH Kim, DN Khalil, IH El Dika, ... JCO Precision Oncology 7, e2300272, 2023 | 2 | 2023 |
| Development of a circulating tumor cell-based RNA classifier for patients with castration-resistant prostate cancer: CTC-PCS/PAM50. PC Teng, YJ Jan, M Kim, JF Chen, J Yoon, JJ Wang, PJ Chen, N Yao, ... Journal of Clinical Oncology 38 (15_suppl), e17509-e17509, 2020 | 1 | 2020 |
| Prostate cancer CTC-RNA Assay: A new method for contemporary genomics and precision medicine via liquid biopsy. PC Teng, YJ Jan, JF Chen, M Kim, N Yao, I Garraway, GCY Chu, PJ Chen, ... Journal of Clinical Oncology 38 (6_suppl), 170-170, 2020 | 1 | 2020 |
| A circulating tumor cell specific RNA assay for assessment of androgen receptor signaling inhibitor sensitivity in metastatic castration-resistant prostate cancer. PC Teng, YJ Jan, J Yoon, PJ Chen, JF Chen, N Yao, S Cheng, A Lozano, ... Journal of Clinical Oncology 37 (15_suppl), 5059-5059, 2019 | 1 | 2019 |
| Life After Critical Illness: A Descriptive Study of Clinical Characteristics and Discharge Locations of Adults After ICU Hospitalization K Sankar, G Cook-Wiens, ME Modes, P Chen A42. TREATING THE WHOLE PERSON IN AND AFTER THE ICU: HOLISTIC ICU CARE, TEAM …, 2024 | | 2024 |
| High dose methotrexate (MTX) treatment: Value of post treatment MTX level monitoring and risk factors for acute kidney injury. R Snyder, A Urazov, M Deh, A Kulkarni, PJ Chen, G Raju, M Tanni, Y Xu Journal of Clinical Oncology 41 (16_suppl), e19539-e19539, 2023 | | 2023 |
| Next-generation sequencing (NGS) of circulating cell-free DNA (cfDNA) in patients (pts) with advanced hepatocellular carcinoma (HCC). D Cowzer, JB White, PJ Chen, TH Kim, D Khalil, IH El Dika, JF Chou, ... Journal of Clinical Oncology 40 (16_suppl), 4110-4110, 2022 | | 2022 |
| Gene expression of circulating tumor cells is predictive of treatment response in patients with advanced prostate cancer PC Teng, M Kim, YJ Jan, JF Chen, N Yao, GC Chu, PJ Chen, JJ Wang, ... Cancer Research 80 (16_Supplement), 5447-5447, 2020 | | 2020 |
| Nuclear size of circulating tumor cells is associated with prognosis in metastatic, castration-resistant prostate cancer JJ Wang, PC Teng, YJ Jan, JF Chen, G Cook-Wiens, N Yao, GC Chu, ... Cancer Research 80 (16_Supplement), 4331-4331, 2020 | | 2020 |
| Purification and mRNA profiling of extracellular vesicles for early detection of hepatocellular carcinoma YT Lee, N Sun, RY Zhang, R Kao, PJ Chen, PC Teng, JJ Wang, Y Yang, ... Cancer Research 80 (16_Supplement), 5436-5436, 2020 | | 2020 |
Edwin PosadasMedical Director, Urologic Oncology Program; Director, Translational Oncology Program, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center在 csmc.edu 的电子邮件经过验证
